Elicio Therapeutics, Inc. (ELTX) vs INmune Bio, Inc. (INMB)
Elicio Therapeutics, Inc. and INmune Bio, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and INmune Bio, Inc. are of similar size ($55.5M and $53.4M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against −51.6%. Across the 14 metrics below, INmune Bio, Inc. leads on 8 and Elicio Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ELTX | INMB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (774.56%) | (74.82%) | (57.72%) |
| Return on assets | (124.36%) | (57.08%) | (49.22%) |
| Return on invested capital | 0.00% | (646.94%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack